Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra J Mandrekar

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Genome Medicine|July 30, 2009
Genomic advances and their impact on clinical trial designSumithra J Mandrekar, Daniel J Sargent
Clinical Trials (London, England)|August 29, 2013
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkersDaniel J Sargent, Sumithra J Mandrekar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical TrialsFangrong Yan, Sumithra J Mandrekar, Ying Yuan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Improving Clinical Trial Efficiency: Thinking outside the BoxSumithra J Mandrekar, Suzanne E Dahlberg, Richard Simon
JAMA Oncology|January 18, 2024
Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer Trials-ReplyShauna L Hillman, Aminah Jatoi, Sumithra J Mandrekar
Chinese Clinical Oncology|September 27, 2015
Molecular and clinical implementations of ovarian cancer mouse avatar modelsAmira A Zayed, Sumithra J Mandrekar, Paul Haluska
Statistics in Medicine|April 27, 2010
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: methods and challengesSumithra J Mandrekar, Rui Qin, Daniel J Sargent
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Missing data and measurement variability in assessing progression-free survival endpoint in randomized clinical trialsRajeshwari Sridhara, Sumithra J Mandrekar, Lori E Dodd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2018
Evaluation of End Points in Cancer Clinical TrialsJun Yin, Suzanne E Dahlberg, Sumithra J Mandrekar
Scandinavian Journal of Gastroenterology|December 21, 2011
Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trialsQian Shi, Sumithra J Mandrekar, Daniel J Sargent
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Genome Medicine|July 30, 2009
Genomic advances and their impact on clinical trial designSumithra J Mandrekar, Daniel J Sargent
Clinical Trials (London, England)|August 29, 2013
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkersDaniel J Sargent, Sumithra J Mandrekar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical TrialsFangrong Yan, Sumithra J Mandrekar, Ying Yuan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Improving Clinical Trial Efficiency: Thinking outside the BoxSumithra J Mandrekar, Suzanne E Dahlberg, Richard Simon
JAMA Oncology|January 18, 2024
Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer Trials-ReplyShauna L Hillman, Aminah Jatoi, Sumithra J Mandrekar
Chinese Clinical Oncology|September 27, 2015
Molecular and clinical implementations of ovarian cancer mouse avatar modelsAmira A Zayed, Sumithra J Mandrekar, Paul Haluska
Statistics in Medicine|April 27, 2010
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: methods and challengesSumithra J Mandrekar, Rui Qin, Daniel J Sargent
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Missing data and measurement variability in assessing progression-free survival endpoint in randomized clinical trialsRajeshwari Sridhara, Sumithra J Mandrekar, Lori E Dodd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2018
Evaluation of End Points in Cancer Clinical TrialsJun Yin, Suzanne E Dahlberg, Sumithra J Mandrekar
Scandinavian Journal of Gastroenterology|December 21, 2011
Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trialsQian Shi, Sumithra J Mandrekar, Daniel J Sargent
Pageof 16